Evaluation of indazole-based compounds as a new class of potent KDR/VEGFR-2 inhibitors

被引：21

作者：

Bauer, David ^{[1
]}

Whittington, Douglas A. ^{[2
]}

Coxon, Angela ^{[4
]}

Bready, James ^{[4
]}

Harriman, Shawn P. ^{[3
]}

Patel, Vinod F. ^{[1
]}

Polverino, Anthony ^{[5
]}

Harmange, Jean-Christophe ^{[1
]}

机构：

[1] Amgen Inc, Dept Med Chem, Cambridge, MA 02139 USA

[2] Amgen Inc, Dept Mol Struct, Cambridge, MA 02139 USA

[3] Amgen Inc, Dept Pharmacokinet & Drug Metab, Cambridge, MA 02139 USA

[4] Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Dept Oncol Res, Seattle, WA 98119 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 17期

关键词：

KDR inhibitor; VEGFR-2; inhibitor; kinase inhibitor;

D O I：

10.1016/j.bmcl.2008.07.080

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel class of potent and selective inhibitors of KDR incorporating an indazole moiety 1 is reported. The discovery, synthesis, and structure-activity relationships of this series of inhibitors have been investigated. The most promising compounds were also pro. led to determine their pharmacokinetic properties and evaluated in a VEGF-induced vascular permeability assay. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：4844 / 4848

页数：5

共 13 条

[1] Kinase inhibition with BAY 43-9006 n renal cell carcinoma
Ahmad, T
Eisen, T
[J]. CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6388S - 6392S
[2] [Anonymous], UNPUB
[3] BELMAN S, 1968, CANCER RES, V28, P535
[4] Efficient Pd-catalyzed amination of heteroaryl halides
Charles, MD
Schultz, P
Buchwald, SL
[J]. ORGANIC LETTERS, 2005, 7 (18) : 3965 - 3968
[5] ANTI-ANGIOGENESIS - NEW CONCEPT FOR THERAPY OF SOLID TUMORS
FOLKMAN, J
[J]. ANNALS OF SURGERY, 1972, 175 (03) : 409 - &
[6] Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
Hicklin, DJ
Ellis, LM
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) : 1011 - 1027
[7] Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors:: Synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N′-{4-[4-quinolyloxy)phenyl}ureas
Kubo, K
Shimizu, T
Ohyama, S
Murooka, H
Iwai, A
Nakamura, K
Hasegawa, K
Kobayashi, Y
Takahashi, N
Takahashi, K
Kato, S
Izawa, T
Isoe, T
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) : 1359 - 1366
[8] Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis
La, Daniel S.
Belzile, Julie
Bready, James V.
Coxon, Angela
DeMelfi, Thomas
Doerr, Nicholas
Estrada, Juan
Flynn, Julie C.
Flynn, Shaun R.
Graceffa, Russell F.
Harriman, Shawn P.
Larrow, Jay F.
Long, Alexander. M.
Martin, Matthew W.
Morrison, Michael J.
Patel, Vinod F.
Roveto, Philip M.
Wang, Ling
Weiss, Matthew M.
Whittington, Douglas A.
Teffera, Yohannes
Zhao, Zhiyang
Polverino, Anthony J.
Harmanget, Jean-Christophe
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1695 - 1705
[9] Rational design of inhibitors that bind to inactive kinase conformations
Liu, Y
Gray, NS
[J]. NATURE CHEMICAL BIOLOGY, 2006, 2 (07) : 358 - 364
[10] VASCULAR REACTIONS TO HISTAMINE, HISTAMINE-LIBERATOR AND LEUKOTAXINE IN THE SKIN OF GUINEA-PIGS
MILES, AA
MILES, EM
[J]. JOURNAL OF PHYSIOLOGY-LONDON, 1952, 118 (02): : 228 - 257

← 1 2 →